INO icon

Inovio Pharmaceuticals
INO

Overview Fund Activity

127 hedge funds and large institutions have $171M invested in Inovio Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+2
Holders Change %
+1.6%
% of All Funds
2.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
50
Reduced
26
Closed
10
Calls
$267K
Puts
$383K
Net Calls
-$116K
Net Calls Change
-$523K

Top Buyers

1
NAMA
Nikko Asset Management Americas
New York
$12.2M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
$11.9M
3
AIM
ARK Investment Management
Florida
$10.9M
4
State Street
State Street
Massachusetts
$15.6M
5
WA
Wasatch Advisors
Utah
$21.8M

Top Sellers

1
OAM
Oxford Asset Management
United Kingdom
$121K
2
UBS Group
UBS Group
Switzerland
$1.04M
3
Citigroup
Citigroup
New York
$273K
4
Morgan Stanley
Morgan Stanley
New York
$477K
5
Federated Hermes
Federated Hermes
Pennsylvania
$16K
Name Holding Trade Value Shares
Change 		Shares
Change %
PM
126
Pembroke Management
Quebec, Canada
– -$52K -1,083 Closed
Creative Planning
127
Creative Planning
Kansas
– -$45K -929 Closed
Susquehanna International Group
128
Susquehanna International Group
Pennsylvania
– -$44K -913 Closed
TRCT
129
Tower Research Capital (TRC)
New York
– -$2K -47 Closed
PA
130
Parallel Advisors
California
– -$1K -26 Closed
AIC
131
Ameritas Investment Company
Nebraska
– -$1K -15 Closed
2 3 4 5
6